215 related articles for article (PubMed ID: 34436341)
1. Membrane Nanoscopic Organization of D2L Dopamine Receptor Probed by Quantum Dot Tracking.
Kovtun O; Torres R; Bellocchio LG; Rosenthal SJ
Membranes (Basel); 2021 Jul; 11(8):. PubMed ID: 34436341
[TBL] [Abstract][Full Text] [Related]
2. Single Quantum Dot Tracking Unravels Agonist Effects on the Dopamine Receptor Dynamics.
Kovtun O; Torres R; Ferguson RS; Josephs T; Rosenthal SJ
Biochemistry; 2021 Apr; 60(13):1031-1043. PubMed ID: 32584548
[TBL] [Abstract][Full Text] [Related]
3. Single Quantum Dot Imaging Reveals PKCβ-Dependent Alterations in Membrane Diffusion and Clustering of an Attention-Deficit Hyperactivity Disorder/Autism/Bipolar Disorder-Associated Dopamine Transporter Variant.
Thal LB; Tomlinson ID; Quinlan MA; Kovtun O; Blakely RD; Rosenthal SJ
ACS Chem Neurosci; 2019 Jan; 10(1):460-471. PubMed ID: 30153408
[TBL] [Abstract][Full Text] [Related]
4. Dopamine D2 long receptor-deficient mice display alterations in striatum-dependent functions.
Wang Y; Xu R; Sasaoka T; Tonegawa S; Kung MP; Sankoorikal EB
J Neurosci; 2000 Nov; 20(22):8305-14. PubMed ID: 11069937
[TBL] [Abstract][Full Text] [Related]
5. Absence of D2S dopamine receptor in the prolactin-secreting MMQ pituitary clone: characterization of a wild D2L receptor coupled to native transduction mechanisms.
Ventra C; Meucci O; Grimaldi M; Scorziello A; Porcellini A; Schettini G
J Mol Endocrinol; 1995 Jun; 14(3):375-89. PubMed ID: 7669227
[TBL] [Abstract][Full Text] [Related]
6. Dysbindin-1 modifies signaling and cellular localization of recombinant, human D₃ and D₂ receptors.
Schmieg N; Rocchi C; Romeo S; Maggio R; Millan MJ; Mannoury la Cour C
J Neurochem; 2016 Mar; 136(5):1037-51. PubMed ID: 26685100
[TBL] [Abstract][Full Text] [Related]
7. Neuroleptics with differential affinities at dopamine D2 receptors and sigma receptors affect differently the N-methyl-D-aspartate-induced increase in intracellular calcium concentration: involvement of protein kinase.
Hayashi T; Su TP; Kagaya A; Nishida A; Shimizu M; Yamawaki S
Synapse; 1999 Jan; 31(1):20-8. PubMed ID: 10025680
[TBL] [Abstract][Full Text] [Related]
8. Dopamine D2S and D2L receptors may differentially contribute to the actions of antipsychotic and psychotic agents in mice.
Xu R; Hranilovic D; Fetsko LA; Bucan M; Wang Y
Mol Psychiatry; 2002; 7(10):1075-82. PubMed ID: 12476322
[TBL] [Abstract][Full Text] [Related]
9. Distinct regulation of internalization and mitogen-activated protein kinase activation by two isoforms of the dopamine D2 receptor.
Kim SJ; Kim MY; Lee EJ; Ahn YS; Baik JH
Mol Endocrinol; 2004 Mar; 18(3):640-52. PubMed ID: 14684845
[TBL] [Abstract][Full Text] [Related]
10. Normalizing dopamine D2 receptor-mediated responses in D2 null mutant mice by virus-mediated receptor restoration: comparing D2L and D2S.
Neve KA; Ford CP; Buck DC; Grandy DK; Neve RL; Phillips TJ
Neuroscience; 2013 Sep; 248():479-87. PubMed ID: 23811070
[TBL] [Abstract][Full Text] [Related]
11. The effects of dopamine and D2 receptor antagonists on pituitary hormone secretion are intact in mice lacking dopamine D2L receptor.
Xu R; Parlow AF; Wang Y
Brain Res; 2002 Jun; 939(1-2):95-9. PubMed ID: 12020855
[TBL] [Abstract][Full Text] [Related]
12. Atypical antipsychotics: mechanism of action.
Seeman P
Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
[TBL] [Abstract][Full Text] [Related]
13. The D2S and D2L dopamine receptor isoforms are differentially regulated in Chinese hamster ovary cells.
Zhang LJ; Lachowicz JE; Sibley DR
Mol Pharmacol; 1994 May; 45(5):878-89. PubMed ID: 7910658
[TBL] [Abstract][Full Text] [Related]
14. Comparison of in vitro binding properties of a series of dopamine antagonists and agonists for cloned human dopamine D2S and D2L receptors and for D2 receptors in rat striatal and mesolimbic tissues, using [125I] 2'-iodospiperone.
Leysen JE; Gommeren W; Mertens J; Luyten WH; Pauwels PJ; Ewert M; Seeburg P
Psychopharmacology (Berl); 1993; 110(1-2):27-36. PubMed ID: 7870895
[TBL] [Abstract][Full Text] [Related]
15. The Gαi protein subclass selectivity to the dopamine D
Polit A; Rysiewicz B; Mystek P; Błasiak E; Dziedzicka-Wasylewska M
Cell Commun Signal; 2020 Dec; 18(1):189. PubMed ID: 33308256
[TBL] [Abstract][Full Text] [Related]
16. Analysis of neuroleptic binding affinities and potencies for the different human D2 dopamine receptor missense variants.
Cravchik A; Sibley DR; Gejman PV
Pharmacogenetics; 1999 Feb; 9(1):17-23. PubMed ID: 10208638
[TBL] [Abstract][Full Text] [Related]
17. Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites.
Lindgren N; Usiello A; Goiny M; Haycock J; Erbs E; Greengard P; Hokfelt T; Borrelli E; Fisone G
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4305-9. PubMed ID: 12651945
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of dopamine D2 receptor isoforms tagged with green fluorescent protein.
Sedaghat K; Nantel MF; Ginsberg S; Lalonde V; Tiberi M
Mol Biotechnol; 2006 Sep; 34(1):1-14. PubMed ID: 16943566
[TBL] [Abstract][Full Text] [Related]
19. Development of polyclonal anti-D2 dopamine receptor antibodies using sequence-specific peptides.
Boundy VA; Luedtke RR; Artymyshyn RP; Filtz TM; Molinoff PB
Mol Pharmacol; 1993 May; 43(5):666-76. PubMed ID: 8502224
[TBL] [Abstract][Full Text] [Related]
20. Cocaine-induced adaptation of dopamine D2S, but not D2L autoreceptors.
Robinson BG; Condon AF; Radl D; Borrelli E; Williams JT; Neve KA
Elife; 2017 Nov; 6():. PubMed ID: 29154756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
